CellaVision
123.20 SEK
+2.33 %
1,477 following
CEVI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+2.33 %
-18.19 %
-19.69 %
-21.63 %
-23.00 %
-35.83 %
-31.63 %
-65.06 %
+689.74 %
CellaVision operates in the medical technology industry and focuses on the development and manufacture of systems for digital blood analysis. The company focuses on digital cell morphology and offers innovations for analyzers, instruments, reagents and software used in hematology laboratories. The company's products are aimed at healthcare institutions and laboratories worldwide. CellaVision was founded in 1994 and is headquartered in Lund, Sweden.
Read moreMarket cap
2.94B SEK
Turnover
3.31M SEK
Revenue
758.97M
EBIT %
26.62 %
P/E
19.19
Dividend yield-%
2.23 %
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
17.7
2026
Interim report Q2'26
29.10
2026
Interim report Q3'26
4.2
2027
Annual report '26
All
Webcasts
Press releases
ShowingAll content types
CellaVision, Audiocast, Q1'26
Softer quarter due to lower sales in EMEA
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
